Identity
HGNC
LOCATION
3p14.3
LOCUSID
ALIAS
DHP2,DNAS1L3,LSD,SLEB16
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 1776
MIM: 602244
HGNC: 2959
Ensembl: ENSG00000163687
Variants:
dbSNP: 1776
ClinVar: 1776
TCGA: ENSG00000163687
COSMIC: DNASE1L3
RNA/Proteins
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38108119 | 2024 | Deoxyribonuclease 1-like 3 inhibits colorectal malignancy through antagonizing NEDD4-triggered CDKN1A ubiquitination. | 0 |
| 38246176 | 2024 | [Decreased DNase1L3 secretion and associated antibodies induce impaired degradation of NETs in patients with sporadic SLE]. | 0 |
| 38744839 | 2024 | Double-negative B cells and DNASE1L3 colocalise with microbiota in gut-associated lymphoid tissue. | 0 |
| 38108119 | 2024 | Deoxyribonuclease 1-like 3 inhibits colorectal malignancy through antagonizing NEDD4-triggered CDKN1A ubiquitination. | 0 |
| 38246176 | 2024 | [Decreased DNase1L3 secretion and associated antibodies induce impaired degradation of NETs in patients with sporadic SLE]. | 0 |
| 38744839 | 2024 | Double-negative B cells and DNASE1L3 colocalise with microbiota in gut-associated lymphoid tissue. | 0 |
| 36708011 | 2023 | Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant. | 0 |
| 36708011 | 2023 | Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant. | 0 |
| 35670985 | 2022 | DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signaling. | 4 |
| 35748106 | 2022 | DNASE1L3 inhibits proliferation, invasion and metastasis of hepatocellular carcinoma by interacting with β-catenin to promote its ubiquitin degradation pathway. | 6 |
| 36327092 | 2022 | DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2. | 2 |
| 35670985 | 2022 | DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signaling. | 4 |
| 35748106 | 2022 | DNASE1L3 inhibits proliferation, invasion and metastasis of hepatocellular carcinoma by interacting with β-catenin to promote its ubiquitin degradation pathway. | 6 |
| 36327092 | 2022 | DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2. | 2 |
| 33035569 | 2021 | A deoxyribonuclease 1-like 3 genetic variant associates with asthma exacerbations. | 3 |
Citation
Dessen P
DNASE1L3 (deoxyribonuclease 1 like 3)
Atlas Genet Cytogenet Oncol Haematol. 2007-02-01
Online version: http://atlasgeneticsoncology.org/gene/43705/dnase1l3
